| 07:00 - 08:15 | 37 | CC1 Lung transplantation | Challenging clinical cases |
| 07:00 - 08:15 | 38 | CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension | Challenging clinical cases |
| 08:30 - 10:30 | 41 | Lung cancer Grand Round | Grand round |
| 08:30 - 10:30 | 42 | State of the art session: Airways disease | Symposium |
| 08:30 - 10:30 | 43 | New Sepsis Surviving Campaign guidelines: back to the “art of medicine” | Symposium |
| 08:30 - 10:30 | 44 | EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease | Symposium |
| 08:30 - 10:30 | 45 | Difficult paediatric lung disease | Symposium |
| 08:30 - 10:30 | 46 | ILDs: From bench to bedside | Oral Presentation |
| 08:30 - 10:30 | 47 | Risk stratification in treatment of pulmonary arterial hypertension | Oral Presentation |
| 08:30 - 10:30 | 48 | Organoids and pluripotent stem cells | Symposium |
| 08:30 - 10:30 | 49 | Respiratory muscles at rest, during exercise and in the critically ill patient | Symposium |
| 08:30 - 10:30 | 50 | Primary care management of respiratory conditions | Oral Presentation |
| 08:30 - 10:30 | 51 | Asthma in children and adults: long-term aspects | Oral Presentation |
| 08:30 - 10:30 | 52 | Prematurity and lung disease | Oral Presentation |
| 08:30 - 10:30 | 53 | Evolving approaches to differential diagnosis | Oral Presentation |
| 08:30 - 10:30 | 54 | Epidemiology and prognostication of critically-ill patients | Poster Discussion |
| 08:30 - 10:30 | 55 | Paediatric asthma: prevention, diagnosis and treatment | Oral Presentation |
| 08:30 - 10:30 | 56 | The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) | Poster Discussion |
| 08:30 - 10:30 | 57 | Occupational and environmental lung diseases: asthma and the airways | Poster Discussion |
| 08:30 - 10:30 | 58 | Evaluation of COPD and various diseases by different imaging modalities | Poster Discussion |
| 08:30 - 10:30 | 59 | EUS-B and EBUS: optimal utilisation of the EBUS scope | Poster Discussion |
| 08:30 - 10:30 | 60 | Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities | Poster Discussion |
| 10:45 - 12:45 | 68 | Imaging Grand Round | Grand round |
| 10:45 - 12:45 | 69 | State of the art session: Pulmonary vascular diseases | Symposium |
| 10:45 - 12:45 | 70 | Cournand lecture: new paradigms in extracorporeal lung assistance | Symposium |
| 10:45 - 12:45 | 71 | Towards understanding and managing chronic cough | Symposium |
| 10:45 - 12:45 | 72 | Dyspnoea: a multidimensional and multidisciplinary approach | Symposium |
| 10:45 - 12:45 | 73 | Imminent global problems in lung cancer require joint action: time for an international alliance! | Hot topics |
| 10:45 - 12:45 | 74 | Mechanisms that underlie exercise limitation in various respiratory diseases | Oral Presentation |
| 10:45 - 12:45 | 75 | Multidisciplinary approach to ground-glass opacities | Symposium |
| 10:45 - 12:45 | 76 | Gene-environment interactions in the omics era | Symposium |
| 10:45 - 12:45 | 77 | Pleural disease: diagnosis, monitoring and management | Oral Presentation |
| 10:45 - 12:45 | 78 | A fresh view on airway differentiation and regeneration | Oral Presentation |
| 10:45 - 12:45 | 79 | Cystic fibrosis: microbiological aspects and new treatments | Oral Presentation |
| 10:45 - 12:45 | 80 | New pharmacological strategies in airway diseases | Oral Presentation |
| 10:45 - 12:45 | 81 | Challenges in treating tuberculosis and nontuberculous mycobacteria | Poster Discussion |
| 10:45 - 12:45 | 82 | Clinical news in idiopathic interstitial pneumonias | Oral Presentation |
| 10:45 - 12:45 | 83 | Assessing pathophysiology in children | Poster Discussion |
| 10:45 - 12:45 | 84 | COPD phenotypes: a1 antitrypsin deficiency and beyond | Poster Discussion |
| 10:45 - 12:45 | 85 | Regenerative and anti-fibrotic approaches | Poster Discussion |
| 10:45 - 12:45 | 86 | Innovative therapies in asthma and COPD | Poster Discussion |
| 10:45 - 12:45 | 87 | Orphan diseases in children | Poster Discussion |
| 12:50 - 14:40 | 93 | Physiological and biological insights in asthma | Thematic Poster |
| 12:50 - 14:40 | 94 | Asthma: clinical screening tools | Thematic Poster |
| 12:50 - 14:40 | 95 | Integrated care and non-pharmacological management of COPD | Thematic Poster |
| 12:50 - 14:40 | 96 | Nutrition and metabolic syndrome in COPD | Thematic Poster |
| 12:50 - 14:40 | 97 | Cardiovascular morbidities in COPD | Thematic Poster |
| 12:50 - 14:40 | 98 | COPD around the world | Thematic Poster |
| 12:50 - 14:40 | 99 | Pharmacological management of COPD | Thematic Poster |
| 12:50 - 14:40 | 100 | Management of bronchiectasis and large airway diseases | Thematic Poster |
| 12:50 - 14:40 | 101 | Management of chronic cough and respiratory muscle dysfunction | Thematic Poster |
| 12:50 - 14:40 | 102 | What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? | Thematic Poster |
| 12:50 - 14:40 | 103 | Imaging of various diseases with different imaging modalities | Thematic Poster |
| 12:50 - 14:40 | 104 | Linear and radial EBUS and peripheral nodules | Thematic Poster |
| 12:50 - 14:40 | 105 | Pleural interventions | Thematic Poster |
| 12:50 - 14:40 | 106 | Primary care management of COPD | Thematic Poster |
| 12:50 - 14:40 | 107 | Functional genomics and COPD: new challenges | Thematic Poster |
| 12:50 - 14:40 | 108 | Studying novel biomarkers in asthma and COPD | Thematic Poster |
| 12:50 - 14:40 | 109 | Identification of therapeutic targets for asthma | Thematic Poster |
| 12:50 - 14:40 | 110 | Pulmonary fibrosis: from models to patients | Thematic Poster |
| 12:50 - 14:40 | 111 | Pulmonary drug delivery: inhaler use, devices and technologies | Thematic Poster |
| 12:50 - 14:40 | 112 | New developments in the treatment of asthma | Thematic Poster |
| 12:50 - 14:40 | 113 | Basic pharmacology | Thematic Poster |
| 12:50 - 14:40 | 114 | Biomarkers for evaluating COPD | Thematic Poster |
| 12:50 - 14:40 | 115 | Biomarkers for evaluating asthma | Thematic Poster |
| 12:50 - 14:40 | 116 | Translational models of the immunopathology that underlies airway obstructive diseases | Thematic Poster |
| 12:50 - 14:40 | 117 | Role of IgE and interleukin (IL)-5 in Th2-cell signatures | Thematic Poster |
| 12:50 - 14:40 | 118 | Epidemiology of asthma and allergy: prevalence, incidence and risk factors | Thematic Poster |
| 12:50 - 14:40 | 119 | Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) | Thematic Poster |
| 12:50 - 14:40 | 120 | Occupational and environmental lung diseases: mechanisms, biomarkers and causation | Thematic Poster |
| 12:50 - 14:40 | 121 | Occupational and environmental lung diseases: influence on the airway and interstitium | Thematic Poster |
| 12:50 - 14:40 | 122 | Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations | Thematic Poster |
| 12:50 - 14:40 | 123 | Effect of tobacco use on health | Thematic Poster |
| 12:50 - 14:40 | 124 | Role of omics in population studies | Thematic Poster |
| 12:50 - 14:40 | 125 | The bad and the ugly in paediatric asthma: comorbidities and exacerbations | Thematic Poster |
| 12:50 - 14:40 | 126 | Paediatric asthma: new mechanisms and tools | Thematic Poster |
| 12:50 - 14:40 | 127 | Cystic fibrosis in adults: current research | Thematic Poster |
| 12:50 - 14:40 | 128 | Clinical problems in paediatric pulmonology | Thematic Poster |
| 12:50 - 14:40 | 129 | Paediatric bronchology | Thematic Poster |
| 12:50 - 14:40 | 130 | Molecular and cellular determinants of the developing lung | Thematic Poster |
| 12:50 - 14:40 | 131 | Respiratory physiology and measurements | Thematic Poster |
| 12:50 - 14:40 | 132 | Acutely hospitalised patients: physiotherapy interventions and assessment methods | Thematic Poster |
| 12:50 - 14:40 | 133 | Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients | Thematic Poster |
| 12:50 - 14:40 | 134 | Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques | Thematic Poster |
| 12:50 - 14:40 | 135 | Chronic respiratory disease : determinants of physical activity in patients | Thematic Poster |
| 12:50 - 14:40 | 136 | Chronic respiratory disease: effects of rehabilitation interventions in patients | Thematic Poster |
| 12:50 - 14:40 | 137 | Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care | Thematic Poster |
| 13:00 - 14:30 | 138 | Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism | Lunchtime session |
| 13:00 - 14:15 | 146 | Interstitial Lung Diseases & Respiratory Infections | Lungs on fire |
| 13:00 - 14:00 | 147 | ME1 Endoscopic lung volume reduction FULLY BOOKED | Meet the expert |
| 13:00 - 14:00 | 149 | ME2 Lung microbiome: study design and standardisation FULLY BOOKED | Meet the expert |
| 13:00 - 14:00 | 150 | ME4 Mucus clearance techniques across respiratory care settings | Meet the expert |
| 14:45 - 16:45 | 164 | Paediatric Year in Review | Year in review |
| 14:45 - 16:45 | 165 | State of the art session: Sleep and breathing disorders | Symposium |
| 14:45 - 16:45 | 166 | Current and evolving tests in lung function: pro/con debate | Symposium |
| 14:45 - 16:45 | 168 | Air pollution and transplantation: near to one's heart and lungs! | Symposium |
| 14:45 - 16:45 | 169 | Interstitial lung disease: an interdisciplinary approach | Symposium |
| 14:45 - 16:45 | 170 | Management of pleural infection in 2018 | Symposium |
| 14:45 - 16:45 | 171 | Best abstracts in pulmonary rehabilitation and chronic care | Oral Presentation |
| 14:45 - 16:45 | 172 | Cleaning agent exposures: are they really harmful to lung health? | Hot topics |
| 14:45 - 16:45 | 173 | Mitochondrial dysfunction as a driver of lung disease | Symposium |
| 14:45 - 16:45 | 174 | On the right path: understanding and improving the function of an overloaded right heart ventricle | Oral Presentation |
| 14:45 - 16:45 | 175 | Educational tools to improve your practice | Oral Presentation |
| 14:45 - 16:45 | 176 | Novel immunology-based therapies in asthma and COPD | Oral Presentation |
| 14:45 - 16:45 | 177 | Clinical trials in COPD: new results | Oral Presentation |
| 14:45 - 16:45 | 178 | New insights in the management of chronic respiratory failure | Poster Discussion |
| 14:45 - 16:45 | 179 | Variant forms of asthma | Oral Presentation |
| 14:45 - 16:45 | 180 | Asthma management | Poster Discussion |
| 14:45 - 16:45 | 181 | Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions | Poster Discussion |
| 14:45 - 16:45 | 182 | Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) | Poster Discussion |
| 14:45 - 16:45 | 183 | Thoracic surgery, pleural effusions and other general thoracic surgery | Poster Discussion |
| 14:45 - 16:45 | 184 | Lung cancer: from early diagnosis to modern monitoring strategies | Poster Discussion |